 And we have to make sure all the federal agencies have the flexibility to allow that and still keep the quality there. And so resiliency within our own country is important, no doubt. You mentioned federal support. Other countries, China, India, subsidize a lot of what their pharmaceutical companies do. We don't really have a level playing field, companies in the U.S.,